Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder for which numerous mouse models have been generated. In both AD patients and mouse models, there is increasing evidence that neuronal dysfunction occurs before the accumulation of β-amyloid (Aβ)-containing plaques and neurodegeneration. Characterization of the timing and nature of preplaque dysfunction is important for understanding the progression of this disease and to identify pathways and molecular targets for therapeutic intervention. Hence, we have examined the progression of dysfunction at the morphological, functional, and behavioral levels in the Tg2576 mouse model of AD. Our data show that decreased dendritic spine density, impaired long-term potentiation (LTP), and behavioral deficits occurred months before plaque deposition, which was first detectable at 18 months of age. We detected a decrease in spine density in the outer molecular layer of the dentate gyrus (DG) beginning as early as 4 months of age. Furthermore, by 5 months, there was a decline in LTP in the DG after perforant path stimulation and impairment in contextual fear conditioning. Moreover, an increase in the Aβ42/Aβ40 ratio was first observed at these early ages. However, total amyloid levels did not significantly increase until ≈18 months of age, at which time significant increases in reactive astrocytes and microglia could be observed. Overall, these data show that the perforant path input from the entorhinal cortex to the DG is compromised both structurally and functionally, and this pathology is manifested in memory defects long before significant plaque deposition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The widely used Tg2576 mouse model expresses mutant human APP and displays decreased spine density in the CA1 and dentate gyrus, well before the development of amyloid plaques, further evidence that soluble Aβ oligomers initiate at least some Alzheimer’s disease–related pathology68,95.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [95]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Whereas high-frequency stimulation significantly increased the magnitude of long-term potentiation (LTP) at Schaffer collateral (SC)-CA1 synapses in the hippocampus of wild type (WT) mice, LTP was significantly impaired in 6-to 7-mo-old APP/PS1 mice (17,18).”
From IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline (2016) · cites this paper as [17]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This is different from the progression in Tg2576, which manifests synaptic damage at an early stage of pathological development (4.5 months) [68,69] with a corresponding decrease in synaptic density markers [70] prior to Aβ plaque development (10 months) [71] and cognitive deficiencies (one year) [72,73].”
From Centella Asiatica Improves Memory and Promotes Antioxidative Signaling in 5XFAD Mice (2019) · cites this paper as [69]
The cited source says what the claim attributes to it.
In the citing paper
“Tg2576 mice began to show impaired LTP and synaptic transmission in dentate gyrus (DG) at 4–5 mo or older (Jacobsen et al., 2006).”
From VPS35 haploinsufficiency increases Alzheimer’s disease neuropathology (2011) · cites this paper as Jacobsen et al., 2006
In the citing paper
“The widely used Tg2576 mouse model expresses mutant human APP and displays decreased spine density in the CA1 and dentate gyrus, well before the development of amyloid plaques, further evidence that soluble Aβ oligomers initiate at least some Alzheimer’s disease–related pathology68,95.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [95]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2005) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,687
Life and Death of Neurons in the Aging Brain
Morrison, J. H., & Hof, P. R. (1997) · Science · doi:10.1126/science.278.5337.412 · Cited by 1,344
Self-citationDeciphering the Molecular Basis of Memory Failure in Alzheimer's Disease
Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207
Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123
Cited by
Items 501–600 of 789
Lesuis, S. L., Lucassen, P. J., & Krugers, H. J. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.07.012 · Cited by 14
Amyloid-β depresses excitatory cholinergic synaptic transmission in Drosophila
Fang, L., Duan, J., Ran, D., Fan, Z., Yan, Y., Huang, N., Gu, H., & Zhu, Y. (2012) · Neuroscience Bulletin · doi:10.1007/s12264-012-1267-x · Cited by 14
Marine bacterial extracts as a new rich source of drugs against Alzheimer’s disease
Zhu, B., Li, Z., Qian, P., & Herrup, K. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14847 · Cited by 13
Song, X., Zhou, H.-Y., Sun, Y., & Huang, H. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05305-w · Cited by 13
Hashimoto, T., Ogino, K., Shin, R., Kitamoto, T., Kikuchi, T., & Shimizu, N. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.12.015 · Cited by 13
Tackling neurodegenerative diseases: animal models of Alzheimer’s disease and Parkinson’s disease
Raslan, A., & Kee, Y. (2013) · Genes & Genomics · doi:10.1007/s13258-013-0116-2 · Cited by 13
Cohen, E. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.08.032 · Cited by 13
Lelos, M. J., Thomas, R. S., Kidd, E. J., & Good, M. A. (2011) · Behavioral Neuroscience · doi:10.1037/a0023415 · Cited by 13
Lü, W., Shu, Y., Zhang, L., Chen, L., Chao, F., Luo, Y., Xiao, Q., Gu, H., Jiang, R., & Tang, Y. C. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160314150709 · Cited by 13
Mhillaj, E., Cuomo, V., & Mancuso, C. (2017) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000296 · Cited by 13
Young Blood Plasma Administration to Fight Alzheimer's Disease?
Aicardi, G. (2017) · Rejuvenation Research · doi:10.1089/rej.2017.1940 · Cited by 13
Whittaker, H. T., Zhu, S., Di Curzio, D. L., Buist, R., Li, X.-M., Noy, S., Wiseman, F. K., Thiessen, J. D., & Martin, M. (2018) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2018.03.010 · Cited by 12
Few-shot prediction of amyloid β accumulation from mainly unpaired data on biomarker candidates
Yada, Y., & Naoki, H. (2023) · npj Systems Biology and Applications · doi:10.1038/s41540-023-00321-5 · Cited by 12
Lv, J., Duan, Y., Wang, X., Wu, H., Chen, J., Zhang, W., Ke, S., Wang, F., Ni, H., & Cao, X. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114271 · Cited by 12
Spicer, M. M., Yang, J., Fu, D., DeVore, A. N., Lauffer, M., Sayar, N., Atasoy, D., & Fisher, R. A. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01993 · Cited by 12
Yu, Y., Liu, S., Wang, H., Shi, D., Xu, Q., Zhou, X., Sun, Z., & Huang, P. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9678-5 · Cited by 12
Kishimoto, Y., Fukumoto, K., Nagai, M., Mizuguchi, A., & Kobashi, Y. (2017) · International Journal of Alzheimer s Disease · doi:10.1155/2017/8584205 · Cited by 12
Lelos, M. J., & Good, M. A. (2012) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2012.03.001 · Cited by 12
Reichelt, A. C., Lin, T. E., Harrison, J. J., Honey, R. C., & Good, M. A. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.05.001 · Cited by 12
Animal Models of Alzheimer’s Disease
Amram, S., & Frenkel, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803690-7.00003-x · Cited by 12
Influence of aging and neurodegeneration on dendritic spine morphology
Bloss, E. B., Morrison, J. H., Hof, P. R., & Dickstein, D. L. (2011) · Translational Neuroscience · doi:10.2478/s13380-011-0008-3 · Cited by 12
Self-citationRole of amyloid β protein receptors in mediating synaptic plasticity
Li, Y., Sun, Z., Cao, Q., Chen, M., Luo, H., Lin, X., & Xiao, F. (2017) · Biomedical Reports · doi:10.3892/br.2017.863 · Cited by 12
Drummond, E., Muhling, J., Martins, R. N., Wijaya, L. K., Ehlert, E., & Harvey, A. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059166 · Cited by 11
Age-Related Progressive Synaptic Dysfunction: The Critical Role of Presenilin 1
Auffret, A., Mariani, J., & Rovira, C. (2010) · Reviews in the Neurosciences · doi:10.1515/revneuro.2010.21.4.239 · Cited by 11
Bozyczko‐Coyne, D., & Williams, M. J. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00168-1 · Cited by 11
Rechnitz, O., Slutsky, I., Morris, G., & Derdikman, D. (2021) · Current Biology · doi:10.1016/j.cub.2021.05.039 · Cited by 11
Classification and Uncertainty Visualization of Dendritic Spines from Optical Microscopy Imaging
Janoos, F., Nouansengsy, B., Xu, X., Machiraju, R., & Wong, S. T. C. (2008) · Computer Graphics Forum · doi:10.1111/j.1467-8659.2008.01220.x · Cited by 11
Alcantara‐Gonzalez, D., Kennedy, M., Criscuolo, C., Botterill, J. J., & Scharfman, H. E. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01747-1 · Cited by 10
Kaar, A., Weir, M. P., & Rae, M. G. (2024) · Neuroscience Letters · doi:10.1016/j.neulet.2024.137664 · Cited by 10
Li, N., Zhang, X., Gu, Z., Su, C., & Lian, H. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-8008 · Cited by 10
The effects of carvacrol and p‐cymene on Aβ1‐42‐induced long‐term potentiation deficit in male rats
Kazemi, S., Safari, S., Komaki, S., Karimi, S. A., Golipoor, Z., & Komaki, A. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14459 · Cited by 10
The Role of Aβ and Tau Oligomers in the Pathogenesis of Alzheimer’s Disease
Bhaskar, K., & Lamb, B. T. (2011) · Springer eBooks · doi:10.1007/978-94-007-2774-8_5 · Cited by 10
Why Alzheimer’s is a Disease of Memory: Synaptic Targeting by Pathogenic Aβ Oligomers (ADDLs)
Klein, W. L., Felice, F. G. D., Lacor, P. N., Lambert, M. P., & Zhao, W.-Q. (2008) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-540-76330-7_9 · Cited by 10
Sun, Y., Zhao, J. W., Lu, Y., Ngo, F. Y., Shuai, B., Zhang, Z., Feng, Y., & Rong, J. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666240515090434 · Cited by 9
Loss of GDE2 leads to complex behavioral changes including memory impairment
Daudelin, D., Westerhaus, A., Zhang, N., Leyder, E. C., Savonenko, A. V., & Sockanathan, S. (2024) · Behavioral and Brain Functions · doi:10.1186/s12993-024-00234-1 · Cited by 9
Eimerbrink, M. J., Pendry, R., Hodges, S. L., Wiles, J. D., Peterman, J. L., White, J. D., Hayes, H. B., Chumley, M. J., & Boehm, G. W. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.07.013 · Cited by 9
Neurophysiological alterations in the nucleus reuniens of a mouse model of Alzheimer's disease
Walsh, D. A., Brown, J. T., & Randall, A. D. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.12.006 · Cited by 9
Gnanaprakash, M., Staniszewski, A., Zhang, H., Pitstick, R., Kavanaugh, M. P., Arancio, O., & Nicholls, R. E. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200462 · Cited by 9
Rice, S. G., Nowak, L., Duysen, E. G., Lockridge, O., Lahiri, D. K., & Reyes, P. F. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11410 · Cited by 9
Kuhn, M. K., Kang, R. Y., Kim, C., Tagay, Y., Morris, N., Tabdanov, E. D., Elcheva, I. A., & Proctor, E. A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.16.567220 · Cited by 9
Heuer, S. E., Nickerson, E. W., Howell, G. R., & Bloss, E. B. (2023) · Aging Cell · doi:10.1111/acel.14033 · Cited by 8
Electrophysiological insights into Alzheimer's disease: A review of human and animal studies
Calvin, K., McNeela, A. M., Osse, A. M. L., Bhasin, G., Ridenour, M., Kinney, J. W., & Hyman, J. M. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105987 · Cited by 8
Fang, K., Pishva, E., Piers, T. M., & Scholpp, S. (2025) · Journal of Cell Science · doi:10.1242/jcs.263526 · Cited by 8
Iqbal, J. (2018) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2018.82005 · Cited by 8
Chakravorty, A., Sharma, A., Sheeba, V., & Manjithaya, R. R. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.842772 · Cited by 8
Lelos, M. J., & Good, M. A. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12527 · Cited by 8
Zhang, X., Hollander, C. M., Khan, M. Y., D’silva, M., Ma, H., Yang, X., Bai, R., Keeter, W. C., Galkina, E., Nadler, J. L., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05304-0 · Cited by 7
Fernández‐Fernández, D., Dorner‐Ciossek, C., Kroker, K. S., & Rosenbrock, H. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23701 · Cited by 7
Phenotypic Assays for β-Amyloid in Mouse Embryonic Stem Cell-Derived Neurons
McIntire, L. B., Landman, N., Kang, M. S., Finan, G. M., Hwang, J. C., Moore, A. Z., Park, L., Lin, C., & Kim, T. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.06.005 · Cited by 7
Yu, Y., Liu, S., Wang, H., Shi, D.-Y., Xu, Q., Zhou, X., Sun, Z., & Huang, P. (2016) · Scientific Reports · doi:10.1038/srep27175 · Cited by 7
Childhood and adolescent obesity and long‐term cognitive consequences during aging
Wang, J., Freire, D., Knable, L. A., Zhao, W., Gong, B., Mazzola, P., Ho, L., Levine, S., & Pasinetti, G. M. (2015) · The Journal of Comparative Neurology · doi:10.1002/cne.23799 · Cited by 7
Zhang, L., Lü, W., Chen, L., Qiu, X., Li, C., Huang, C., Gong, X., Min, Q.-C., Lu, F., Wan, J., et al. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.09.030 · Cited by 7
Chi, H., Zhai, Q., Zhang, M., Su, D., Cao, W., Li, W., She, X., Yang, H., Wang, K., Gao, X., et al. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666210324114153 · Cited by 7
Park, S., Ko, H., Lee, N., Lee, H., Rim, E. Y., Kim, H., Lee, K., & Kaang, B. (2010) · Genes & Genomics · doi:10.1007/s13258-010-0833-8 · Cited by 7
Amyloid-Beta, BDNF, and the Mechanism of Neurodegeneration in Alzheimer’s Disease
Rosa, E., & Fahnestock, M. L. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_43 · Cited by 7
Criscuolo, C., Chartampila, E., Ginsberg, S. D., & Scharfman, H. E. (2023) · eNeuro · doi:10.1523/eneuro.0192-23.2023 · Cited by 6
Opposing interictal dynamics in Alzheimer’s disease and epilepsy
Lisgaras, C. P., & Scharfman, H. E. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102844 · Cited by 6
Huang, N., Hong, R., Cui, X., Cao, L., Shi, L., Chen, B., Su, Y., Xu, X., Hua, C., & Ying, T. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04297-2 · Cited by 6
Matsuura, Y., Ueda, M., Higaki, Y., Watanabe, K., Habara, S., Kamino, S., Saji, H., & Enomoto, S. (2016) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2016.02.007 · Cited by 6
Deletion of Dcf1 Reduces Amyloid-β Aggregation and Mitigates Memory Deficits
Li, W., Gan, L., Ma, F.-F., Feng, R., Wang, J., Li, Y., Sun, Y., Wang, Y.-J., Diao, X., Qian, F.-Y., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200619 · Cited by 6
Höfling, C., Shehabi, E., Kuhn, P., Lichtenthaler, S. F., Hartlage‐Rübsamen, M., & Roßner, S. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00137 · Cited by 6
Pearse, Y., Clarke, D., Kan, S., Le, S. Q., Sanghez, V., Luzzi, A., Pham, I., Nih, L. R., Cooper, J. D., Dickson, P., et al. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.10.013 · Cited by 6
NGF and BDNF Gene Therapy for Alzheimer’s Disease
Tuszynski, M. H., & Nagahara, A. H. (2016) · Springer eBooks · doi:10.1007/978-1-4899-7654-3_3 · Cited by 6
Manipulating memory in space and time
Roy, D. S., & Tonegawa, S. (2017) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2017.05.020 · Cited by 6
From Green Bacteria to Human Dementia: A Novel Model for Discovering Amyloid Assembly Inhibitors
Gazit, E. (2006) · ACS Chemical Biology · doi:10.1021/cb600328c · Cited by 6
Synaptic Plasticity in the Hippocampus
Bliss, T., Collingridge, G. L., Cooke, S. F., Georgiou, J., & Morris, R. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780190065324.003.0010 · Cited by 5
Matthews, D. G., Khorani, M., Bobe, G., Caruso, M. A., Magaña, A. A., Gray, N. E., Quinn, J. F., Stevens, J. F., Maier, C. S., & Soumyanath, A. (2024) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823241296740 · Cited by 5
Lelos, M. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818084-6.00002-7 · Cited by 5
Bergamini, G., Massinet, H., Durkin, S., & Steiner, M. A. (2022) · Physiology & Behavior · doi:10.1016/j.physbeh.2022.113787 · Cited by 5
Bitan, F. R. A. G. (2014) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781608058525114020014 · Cited by 5
Enhancing Synaptogenesis in Diseases Characterized by Deficiencies in Brain Synapses
Wurtman, R. J. (2010) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2010.00147 · Cited by 5
Developing injectable immunoglobulins to treat cognitive impairment in Alzheimer's disease
Steinitz, M. O. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.5.633 · Cited by 5
Lilja, A. M., Röjdner, J., Mustafiz, T., Thomé, C. M., Storelli, E., Gonzalez, D., Lithner, C. U., Greig, N. H., Nordberg, A. K., & Marutle, A. (2013) · PLoS ONE · doi:10.1371/annotation/79c850e6-4494-4533-b68d-ef4eb72cd65a · Cited by 5
Wang, B., Wang, Z., Lv, L., Wang, X., Lu, J., Zhao, Y., Jiang, R., Li, Q., Kong, Y., Yang, X., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70633 · Cited by 4
Doshmanziari, M., Sarveazad, A., Moradi, F., Simorgh, S., Shariatpanahi, M., & Eftekharzadeh, M. (2025) · Brain Disorders · doi:10.1016/j.dscb.2025.100285 · Cited by 4
Lisgaras, C. P., & Scharfman, H. E. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71154 · Cited by 4
Decoding the mechanisms of amyloid-β in synaptic toxicity
Toruński, P., Pizzirusso, G., Winblad, B. G., & Arroyo‐García, L. E. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261424292 · Cited by 4
The Value of the Object Recognition Paradigm in Investigating Animal Models of Alzheimer's Disease
Mathis, C. (2018) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-812012-5.00021-5 · Cited by 4
Estimating the synaptic density deficit in Alzheimer’s disease using multi-contrast CEST imaging
Shahid, S. S., Džemidžić, M., Butch, E. R., Jarvis, E., Snyder, S. E., & Wu, Y. (2024) · PLoS ONE · doi:10.1371/journal.pone.0299961 · Cited by 4
Aliakbari, S., Hasanzadeh, L., Sayyah, M., Amini, N., & Pourbadie, H. G. (2024) · Journal of NeuroVirology · doi:10.1007/s13365-024-01221-y · Cited by 4
Apoptosis is an obstacle to the differentiation of adipose-derived stromal cells into astrocytes
Yuan, X., Sun, Q., Ou, Y., Wang, S., Zhang, W., Deng, H., Wu, X., & Zhang, L. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.131600 · Cited by 4
Montag, D., Pelz, L., & Rathjen, F. G. (2023) · PLoS ONE · doi:10.1371/journal.pone.0280133 · Cited by 4
Models of Dementia: an introductory overview
Graham, L., & Sutherland, C. D. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390851 · Cited by 4
Ono, K., Zhao, D., Wu, Q., Simon, J. E., Wang, J., Radu, A., & Pasinetti, G. M. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-209007 · Cited by 4
Colacurcio, D. J., Zyskind, J. W., Jordan‐Sciutto, K. L., & Akay, C. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.10.031 · Cited by 4
Sohre, S., & Moosmann, B. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/418566 · Cited by 4
Uncovering the dark transcriptome in polarized neuronal compartments with mcDETECTPreprint
Yuan, C., Patel, K., Shi, H., Wang, H. V., Wang, F., Li, R.-H., Li, Y., Corces, V. G., Shi, H., Das, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.27.645744 · Cited by 5
Amyloidopathy in the Eye of Alzheimer′s Disease
Zhang, X. (2011) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s5-005 · Cited by 3
From stress to Alzheimer’s: A circuit-based framework for prefrontal cognitive dysfunction
Yi, J. H. (2025) · Neuroscience Letters · doi:10.1016/j.neulet.2025.138424 · Cited by 3
Nitric oxide signaling in Alzheimer's disease: A double-edged sword
Wasim, R. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178986 · Cited by 3
Sabec, M. H., Savage, Q. R., Wood, J. L., & Maskos, U. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02666-7 · Cited by 3
Dejakaisaya, H., Lin, R., Harutyunyan, A., Chan, J., Kwan, P., & Jones, N. C. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241289053 · Cited by 3
Latina, V., Introna, M. D., Caligiuri, C., Loviglio, A., Florio, R., Regina, F. L., Pignataro, A., Ammassari‐Teule, M., Calissano, P., & Amadoro, G. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020509 · Cited by 3
Aguilera, M., Mathis, C., Herbeaux, K., Isik, A., Faranda, D., Battaglia, D. A., & Goutagny, R. (2025) · Imaging Neuroscience · doi:10.1162/imag.a.70 · Cited by 3
Shea, T. B. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.07.039 · Cited by 3
Zhao, D.-P., Lei, X., Wang, Y., Ao, X., Zhao, C.-Y., Xu, Y., Zhang, Y., Liu, G., Geng, F., Xu, H., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.971385 · Cited by 3
Rentsch, P., Ganesan, K., Langdon, A., Konen, L. M., & Vissel, B. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1421900 · Cited by 4
Dickstein, D. L., Morrison, J. H., & Hof, P. R. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195328875.003.0003 · Cited by 4
Self-citationCampos, J. (2013) · Journal of Antivirals & Antiretrovirals · doi:10.4172/jaa.s10-003 · Cited by 3
Roy, D. S., & Tonegawa, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.21124-3 · Cited by 3
Metadata
- Authors
- Jacobsen, J. S., Wu, C.-C., Redwine, J. M., Comery, T. A., Arias, R., Bowlby, M., Martone, R., Morrison, J. H., Pangalos, M. N., Reinhart, P. H., & Bloom, F. E.
- Affiliations
- Wyeth (US)
- Neurome, Inc., La Jolla, CA 92037; and
- Icahn School of Medicine at Mount Sinai (US)
- Scripps Research Institute (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-03-20
- Volume
- 103
- Issue
- 13
- Pages
- 5161-5166
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1405622
- OpenAlex
- W2136901555
- Cited by
- 701
- References
- 44
- Citations by year
- 2026: 17 · 2025: 16 · 2024: 26 · 2023: 31 · 2022: 24 · 2021: 32 · 2020: 26 · 2019: 32 · 2018: 35 · 2017: 28 · 2016: 42 · 2015: 26 · 2014: 40 · 2013: 35 · 2012: 46
- FWCI
- 30.71
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, dendritic spine density, long-term potentiation, dentate gyrus, perforant path, contextual fear conditioning, memory impairment, amyloid-beta 42/40 ratio, amyloid plaques, reactive astrocytes, microglia, entorhinal cortex
- MeSH terms
- Aging, Alzheimer Disease, Animals, Behavior, Animal, Brain, Disease Models, Animal, Fear, Memory, Mice, Transgenic, Organ Size, Spine, Synapses, Time Factors, Amyloid beta-Peptides, Synaptophysin, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.